Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Posch

Showing results (891-900 of 1,203) with videos related to

Pageof 121
Sort By:
Annals of Surgical Oncology|August 28, 2019
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant TherapyHannah Deborah Müller, Florian Posch, Christoph Suppan, et al.
Biomedicines|August 27, 2021
Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and LimitationsLukas Lüftinger, Ines Ferreira, Bernhard J H Frank, et al.
Plos One|February 25, 2025
Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trialNiklas Walther, Robert Schultz-Heienbrok, Heino Staß, et al.
Nature Cell Biology|March 5, 2013
Ubiquitylation-dependent localization of PLK1 in mitosisJochen Beck, Sarah Maerki, Markus Posch, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Frontiers in Medicine|October 31, 2025
A model structure for describing uncertainties in benefit-risk assessment of oncology drug applicationsNikolaos Zafiropoulos, Francesco Pignatti, Andreas Kouroumalis, et al.
Heart Rhythm|March 28, 2009
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudesMaximilian G Posch, Andreas Perrot, Christian Geier, et al.
Thrombosis Research|July 12, 2005
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteersDaniel J Brotman, John P Girod, Amy Posch, et al.
Thrombosis Research|August 28, 2017
Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI)Oliver Königsbrügge, Matthias Lorenz, Martin Auinger, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Pageof 121

Showing results (891-900 of 1,203) with videos related to

Sort By:
Pageof 121
Annals of Surgical Oncology|August 28, 2019
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant TherapyHannah Deborah Müller, Florian Posch, Christoph Suppan, et al.
Biomedicines|August 27, 2021
Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and LimitationsLukas Lüftinger, Ines Ferreira, Bernhard J H Frank, et al.
Plos One|February 25, 2025
Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trialNiklas Walther, Robert Schultz-Heienbrok, Heino Staß, et al.
Nature Cell Biology|March 5, 2013
Ubiquitylation-dependent localization of PLK1 in mitosisJochen Beck, Sarah Maerki, Markus Posch, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2018
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolismP Mir Seyed Nazari, J Riedl, M Preusser, et al.
Frontiers in Medicine|October 31, 2025
A model structure for describing uncertainties in benefit-risk assessment of oncology drug applicationsNikolaos Zafiropoulos, Francesco Pignatti, Andreas Kouroumalis, et al.
Heart Rhythm|March 28, 2009
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudesMaximilian G Posch, Andreas Perrot, Christian Geier, et al.
Thrombosis Research|July 12, 2005
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteersDaniel J Brotman, John P Girod, Amy Posch, et al.
Thrombosis Research|August 28, 2017
Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIVALDI)Oliver Königsbrügge, Matthias Lorenz, Martin Auinger, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Pageof 121